COVID-19 Rapid Tests Available

Rapid diagnostic test (RDT) relies on a lateral flow assay that returns qualitative (positive or negative) results within minutes. A small blood sample is placed at one end of the test strip, and the antibodies of interest in the blood sample interact with tagged proteins embedded in the test.

The test displays colored lines at the end of the strip corresponding to a positive, negative, or inconclusive result with respect to the presence of the desired antibodies. RDTs are not capable of providing quantitative results indicating the amount of the antibodies in the specimen.

They are small, portable, and can be used at pointof-care (POC). In the context of COVID-19, RDTs most frequently test for the presence of patient antibodies {lgM and lgG) specific to SARS-CoV-2.

Need more information?

About the test

A rapid test for the qualitative detection of antibodies IgG and IgM to SARS-CoV-2 in whole blood, serum, or plasma. The test utilizes a combination of SARS-CoV-2 antigen coated colored particles for the detection of these antibodies.

Who can purchase the COVID-19 test?

For healthcare professional in-vitro use. Each package includes test cassette , buffer, safety lancet, alcohol swab, disposable dropper, package insert.

About the results

Results in less than 15 minutes. Proper reporting to the local Department of Health required. PharmcoRx is able to manage reporting for you!

FDA information

Our tests are manufactured in Finland and FDA registered. Click here for more information about our FDA registration.

Ready to get the test?